Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$0.51 - $0.93 $26,784 - $48,841
-52,518 Reduced 98.1%
1,015 $1,000
Q1 2022

May 12, 2022

BUY
$0.84 - $1.71 $23,882 - $48,617
28,431 Added 113.26%
53,533 $45,000
Q4 2021

Feb 10, 2022

BUY
$1.59 - $2.38 $21,641 - $32,394
13,611 Added 118.45%
25,102 $41,000
Q3 2021

Nov 10, 2021

BUY
$1.69 - $2.89 $19,419 - $33,208
11,491 New
11,491 $28,000

Others Institutions Holding SEEL

# of Institutions
1
Shares Held
40.5K
Call Options Held
0
Put Options Held
0

About SEELOS THERAPEUTICS, INC.


  • Ticker SEEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 106,691,000
  • Market Cap $109M
  • Description
  • Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...
More about SEEL
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.